SUNNY

📅 Upcoming

🕒 Recent(90d)

News

• STAT+: Moderna CEO on what’s next after success in cancer vaccine
  Moderna's CEO Stéphane Bancel on what's next after the recent success of a cancer vaccine, and how that impacts the company's business strategy.
  stat · 9d ago
• Why I wish you didn’t want to see Nathan Fielder’s Elizabeth Holmes documentary
  A reporter who interviewed Elizabeth Holmes on why society confuses authenticity, honesty, and truth, and how she takes advantage.
  stat · 14d ago
• Opinion: I was a Theranos whistleblower. In ‘You Can See Everything,’ Elizabeth Holmes is still lying
  A more accurate name would be “You Can See Everything That We Chose To Point The Camera At,”Theranos whistleblower Tyler Shultz writes.
  stat · 15d ago
• What to read before you go see that new documentary on Elizabeth Holmes
  Ahead of "You Can See Everything" hitting theaters, let's rewind the last decade and review some of the most significant news tied to Elizabeth Holmes, who was convicted in 2022…
  stat · 18d ago
• A mother-daughter quest to find fellow members of an ultra-rare genetic community
  “Don’t google,” the pediatric geneticist warned. It took me five years to disobey.
  stat · 27d ago
• STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more
  A final Medicare rule aimed at lowering prices for doctor-administered drugs applies to only four companies and saves 96% less than the initial proposal
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more
  Western pharmaceutical companies are urging the Trump administration to allow them to keep doing deals with Chinese companies for drug candidates
  stat · 1mo ago
• Steady stream of crossover rounds stock biotech's IPO pipeline
  Biotech crossover rounds could top $4.22 billion across about 28 rounds this year, PitchBook forecasts.
  biospace · 1mo ago
• STAT+: Pharmalittle: We’re reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
  The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to attack a genetic cause
  stat · 2mo ago
• STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
  Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell short of its primary goal
  stat · 2mo ago